Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Inhibitory Effect of Coicis Semen Composition on Inflammatory Responses in the Collagen-induced Arthritis Mouse Model

  • Moon, Jung-Won (Department of Oriental Medicine, Oriental Rehabilitation Medicine Daejeon University) ;
  • Oh, Min-Suck (Department of Oriental Medicine, Oriental Rehabilitation Medicine Daejeon University)
  • Published : 2006.10.25
Download PDF
⟨ Previous Next ⟩

Abstract

This study was peformed to investigate possible mechanisms underlying possible effect of Coicis Semen composition (CSC) on inflammatory diseases using in vivo model of RA in the mice. Results are summarized as follows. In production of inflammatory cytokines, INF-${\gamma}$ in the spleen and IL-6 in the serum were decreased by CSC treatment. TNF-${\alpha}$ in serum was significantly decreased, IL-4 in the spleen was significantly increased by CSC treatment. In production of rheumatoid factors, IgM and IgG were significantly decreased by CSC treatment. The present data suggest that CSC treatment can improve pathological damage by CIA. So we expect that CSC should be used as a effective drugs for not only rheumatoid arthritis but also another autoimmune disease. Therefore we have to survey continuously in looking for the effective substance and mechanism in the future.

Keywords

References

  1. Sayah, A. English JC 3rd, Rheumatoid arthritis, a review of the cutaneous manifestations, J Am Acad Dermatol, Aug; 53(2):191-209, 2005 https://doi.org/10.1016/j.jaad.2004.07.023
  2. Setty, A.R., Sigal, L.H. Herbal medications commonly used in the practice of rheumatology; mechanisms of action efficacy and side effects, Semin Arthritis Rheum, 34(6):773-784, 2005 https://doi.org/10.1016/j.semarthrit.2005.01.011
  3. D.M. Lee, and M.E. Weinblatt, Rheumatoid arthritis, Lancet, 358:903-911, 2001 https://doi.org/10.1016/S0140-6736(01)06075-5
  4. Aho, K., Koskenvuo, M., Tuominen, J., Kaprio, J. Occurrence of rheumatoid arthritis in a nationwide series of twins, J Rheumatol, 13(5):899-902, 1986
  5. Aho, K., Palosuo, T., Raunio, V., Puska, P., Aromaa, A., Salonen, J.T. When does rheumatoid disease start, Arthritis Rheum, 28:485-489, 1985 https://doi.org/10.1002/art.1780280503
  6. Nouri, A.M., Panayi, G.S., Goodman, S.M. Cytokines and the chronic inflammation of rheumatic disease I, The presence of interleukin-1 in synovial fluids, Clin Exp Immunol, 55:295-302, 1984
  7. Di, Giovine, F.S., Nuki, G., Duff, G.W. Tumour necrosis factor in synovial exudates, Ann Rheum Dis, 47:768-772, 1988 https://doi.org/10.1136/ard.47.9.768
  8. Nouri, A.M., Panayi, G.S., Goodman, S.M. Cytokines and the chronic inflammation of rheumatic disease I, The presence of interleukin-1 in synovial fluids, Clin Exp Immunol, 55:295-302, 1984
  9. Blaschke, S., Middel, P., Dorner, B.G., Blaschke, V., Hummel, K.M. and Kroczek, R.A., Reich, K., Benoehr, P., Koziolek, M., Muller, G.A. Expression of activation-induced, T cell-derived and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis, Arthritis Rheum, 48:1858-1872, 2003 https://doi.org/10.1002/art.11171
  10. Morand, E.F., Bucala, R., Leech, M. Macrophage migration inhibitory factor; an emerging therapeutic target in rheumatoid arthritis, Arthritis Rheum, 48:291-299, 2003 https://doi.org/10.1002/art.10728
  11. Bradley, K., Scatizzi, J.C., Shamiyeh, E. Retinoblastoma suppression of matrix metalloproteinase-1 but not interleukin-6, though a p-38-dependent pathway in rheumatoid arthritis synovial fibroblasts, Arthritis Rheum, 50:78-87, 2004 https://doi.org/10.1002/art.11482
  12. Carson, D.A., Pasquali, J.L., Tsoukas, C.D., Fong, S., Slovin, S.F., Lawrance, S.K., Slaughter, L., Vaughan, J.H. Physiology and pathology of rheumatoid factors, Springer Semin Immunopathol, 4:161-179, 1981 https://doi.org/10.1007/BF01857093
  13. Joe, B., Griffiths, M.M., Remmers, E.F., Wilder, R.L. Animal models of rheumatoid arthritis and related inflammation, Curr Rheumatol Rep, 1(2):139-148, 1999 https://doi.org/10.1007/s11926-999-0011-7
  14. Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., Kishimoto, T. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody, Arthritis Rheum, 50:1761-1769, 2004 https://doi.org/10.1002/art.20303
  15. Sutton, B., Corper, A., Bonagura, V., Taussig, M. The structure and origin of rheumatoid factors [comment], Immunol Today, 21:177-183, 2000 https://doi.org/10.1016/S0167-5699(00)01589-9
  16. Tuomi, T., Palosuo, T., Aho, K. The distribution of class-specific rheumatoid factors is similar in rheumatoid and pre-illness sera, Scand J Immunol, 24:751-754, 1986 https://doi.org/10.1111/j.1365-3083.1986.tb02196.x